Pfizer CEO says pharmaceutical companies want to work with Trump to make medicine more affordable
This move comes after Trump demanded that 17 drugmakers expand direct-to-consumer options and lower prices to match those in other industrialized countries, threatening to use 'every tool' if they did not comply.
Pfizer and Bristol Myers Squibb have already revealed plans to offer their blood thinner Eliquis at a lower price online, building on Pfizer's existing direct-to-consumer telehealth and prescription services.
Other companies, such as Eli Lilly and Novo Nordisk, are also exploring direct access for their obesity drugs, aiming to bypass pharmacy benefit managers.
Despite potential sector-specific tariffs on pharmaceutical imports, which could escalate to 250 percent, Pfizer expects to meet its financial forecasts, though experts have refuted Trump's claims of significant drug price reductions.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Reuters
6 minutes ago
- Reuters
Lawsuit accuses Apple of stealing trade secrets to create Apple Pay
Aug 7 (Reuters) - Apple (AAPL.O), opens new tab has been sued by a Texas company that accused the iPhone maker of stealing its technology to create its lucrative mobile wallet Apple Pay. In a complaint made public on Thursday, Fintiv said Apple Pay's key features were based on technology developed by CorFire, which Fintiv bought in 2014, and now used in hundreds of millions of iPhones, iPads, Apple Watches and MacBooks. Apple did not immediately respond to requests for comment. Fintiv, based in Austin, Texas, said Apple held multiple meetings in 2011 and 2012 and entered nondisclosure agreements with CorFire aimed at licensing its mobile wallet technology, to capitalize on fast-growing demand for contactless payments. Instead, and with the help of CorFire employees it lured away, Apple used the technology and trade secrets to launch Apple Pay in the United States and dozens of other countries, beginning in 2014, the complaint said. Fintiv also said Apple has led an informal racketeering enterprise by using Apple Pay to generate fees for credit card issuers such as Bank of America, Capital One, Citigroup, JPMorgan Chase and Wells Fargo, and the payment networks American Express, Mastercard and Visa. "This is a case of corporate theft and racketeering of monumental proportions," enabling Cupertino, California-based Apple to generate billions of dollars of revenue without paying Fintiv "a single penny," the complaint said. In a statement, Fintiv's lawyer Marc Kasowitz called Apple's conduct "one of the most egregious examples of corporate malfeasance" he has seen in 45 years of law practice. The lawsuit in Atlanta federal court seeks compensatory and punitive damages for violations of federal and Georgia trade secrets and anti-racketeering laws, including RICO. Apple is the only defendant. CorFire was based in Alpharetta, Georgia, an Atlanta suburb. On August 4, a federal judge in Austin dismissed Fintiv's related patent infringement lawsuit against Apple, four days after rejecting some of Fintiv's claims, court records show. Fintiv agreed to the dismissal, and plans to "appeal on the existing record," the records show. The case is Fintiv Inc v Apple Inc, U.S. District Court, Northern District of Georgia, No. 25-04413.
Metro
7 minutes ago
- Metro
Will Trump make way for oldest frenemy Steve Bannon to run for president?
There was a time when Donald Trump floated seeking an unprecedented third presidential term — but now, a sometimes friend, sometimes enemy of his is reportedly plotting a run in 2028. Trump's brief White House chief strategist during his first term, Steve Bannon, has started gathering political advice for a potential bid, sources close to both Republicans told the Daily Mail on Thursday. Bannon, 71, behind closed doors has mocked the possible scenario of Vice President JD Vance running to be Trump's successor, one source told the news outlet. 'Love him… but Vance is not tough enough to run in 2028,' Bannon has said, according to several people in his circle. Bannon is a populist political strategist and media executive who has hosted the War Room podcast since 2019. He served as chief strategist and senior counselor to the president from the start of Trump's first term in January 2016, for seven months. He then left and rejoined the far-right syndicated news site which he co-founded, Breitbart. Bannon was a Navy officer and worker as an investment banker for Goldman Sachs for two years. He also worked as an executive producer of Hollywood films until Trump won the 2016 election. In one of the lower points of his career, Bannon in 2022 was charged with money laundering, conspiracy and scheming to defraud for his alleged part in a group that raised $15million to build a wall at the border with Mexico but skimmed the donated funds. Trump has repeatedly mentioned the idea of running for a third term — even though the US Constitution prohibits it. The 22nd Amendment, added to the Constitution in 1951, states: 'No person shall be elected to the office of the President more than twice, and no person who has held the office of President, or acted as President, for more than two years of a term to which some other person was elected President shall be elected to the office of the President more than once.' To get around that, Trump's allies have raised the hypothetical situation of Vance running for president successfully with Trump as vice president, and then immediately resigning to allow his current boss to be commander-in-chief. But asked by CNBC on Tuesday if he would run in 2028, Trump said: 'No, probably not, probably not. I'd like to… I have the best poll numbers I've ever had.' Still, he hasn't taken it off the table. Trump and Bannon have had a rollercoaster relationship over the years. More Trending They appear to be in good terms recently, with Bannon going so far as vouching for Trump's possible 2028 run. 'I'm a firm believer that President Trump will run and win again in 2028. We've had greater long shots than Trump 2028,' Bannon told News Nation in March. Trump has forgiven people in the past, especially when it benefits his political career, but would conceivably quickly turn on Bannon if they were both to run in 2028. If the race for the GOP nomination were to be between Bannon and Vance, Trump's loyalty remains to be seen. Get in touch with our news team by emailing us at webnews@ For more stories like this, check our news page. MORE: Two killed after helicopter crashes into boat on the Mississippi River MORE: What could happen if Trump, Putin and Zelensky meet? MORE: South Park's latest savage Donald Trump takedown sparks bizarre reaction from White House
Reuters
8 minutes ago
- Reuters
S&P 500 eases with Eli Lilly; Nasdaq manages record closing high
NEW YORK, Aug 7 (Reuters) - The Dow and S&P 500 eased on Thursday, as shares of Eli Lilly dropped after data from its oral weight loss drug disappointed, while the Nasdaq eked out a record closing high. Just before the session's end, U.S. President Donald Trump said he will nominate Council of Economic Advisors Chairman Stephen Miran to serve out the remaining term of Federal Reserve Governor Adriana Kugler. Miran is due to serve in the role until January 31, 2026, while Trump continues a search for a permanent replacement. Earlier, investors digested a Bloomberg report that Fed Governor Christopher Waller was Trump's top candidate for the U.S. central bank's chair post. Trump has been critical of current Chair Jerome Powell for holding off on cutting borrowing costs. Eli Lilly (LLY.N), opens new tab, which also raised its full-year profit and sales forecast, fell after the orforglipron drug data. The stock ended down 14.1%. Shares of Fortinet (FTNT.O), opens new tab also fell, with the stock finishing 22% lower, after the cybersecurity firm gave a revenue forecast below Wall Street estimates. "The market rally is beginning to look a little bit tired here. We ran up on earnings, and of course the market was basically ignoring a lot of the tariff news," said Peter Cardillo, chief market economist at Spartan Capital Securities in New York. Trump's higher tariffs on imports from dozens of countries kicked in on Thursday, raising the average U.S. import duty to its highest in a century. The Dow Jones Industrial Average (.DJI), opens new tab fell 224.48 points, or 0.51%, to 43,968.64, the S&P 500 (.SPX), opens new tab lost 5.06 points, or 0.08%, to 6,340.00 and the Nasdaq Composite (.IXIC), opens new tab gained 73.27 points, or 0.35%, to 21,242.70. The S&P 500 has hit 15 record closing highs this year, while the Nasdaq has posted 17 all-time closing highs so far in 2025. Among other decliners, chipmaker Intel (INTC.O), opens new tab was down 3.1% after Trump called for the immediate resignation of new Intel CEO Lip-Bu Tan, calling him "highly conflicted" due to his ties to Chinese firms. Helping the Nasdaq, Apple (AAPL.O), opens new tab shares rose 3.2% after the latest tariff salvo from Trump largely exempted industry heavyweights from his threat to impose 100% levy on chips and semiconductors. The U.S. president announced a tariff of about 100% on imports of semiconductors, but said it would not apply to companies that are manufacturing in the U.S. or have committed to do so. Rate cut expectations remained largely the same after the day's data on the labor market. Weekly initial jobless claims rose 7,000 to a seasonally adjusted 226,000, the highest level since the week ended July 5 and slightly above the 221,000 estimate of economists polled by Reuters, according to the data. Market expectations for a September rate cut of at least 25 basis points from the Fed stood at 93.2%, down slightly from the 94.6% in the prior session and well above the 37.7% from a week ago, according to CME's FedWatch Tool. Declining issues outnumbered advancers by a 1.01-to-1 ratio on the NYSE. There were 232 new highs and 80 new lows on the NYSE. On the Nasdaq, 1,944 stocks rose and 2,622 fell as declining issues outnumbered advancers by a 1.35-to-1 ratio. Volume on U.S. exchanges was 17.40 billion shares, compared with the 18.23 billion average for the full session over the last 20 trading days.
